1. 53PImpact of chronic hepatitis virus infection on the feasibility and efficacy for Asian patients with hepatocellular carcinoma in phase I clinical trials. (5th March 2018) Authors: Koyama, T; Kondo, S; Shimizu, T; Fujiwara, Y; Kitano, S; Ebata, T; Shimomura, A; Morizane, C; Okusaka, T; Yamamoto, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 623PDThe nationwide cancer genome screening project in Japan, SCRUM Japan GISCREEN: Efficient identification of cancer genome alterations in advanced biliary tract cancer. (23rd October 2018) Authors: Morizane, C; Komatsu, Y; Takahashi, H; Ueno, M; Furuse, J; Kudo, T; Itoh, S; Shimizu, S; Nakamura, K; Kamata, K; Ohtsubo, K; Mizukami, T; Kagawa, Y; Nomura, S; Kuwata, T; Fujii, S; Okamoto, W; Shitara, K; Ohtsu, A; Yoshino, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 697PA phase I, open-label, multi-center, dose-escalation study of codrituzumab, an anti-glypican-3 monoclonal antibody, in combination with atezolizumab in patients with locally advanced or metastatic hepatocellular carcinoma. (23rd October 2018) Authors: Cheng, A-L; Yen, C-J; Okusaka, T; Ikeda, M; Hsu, C-H; Wu, S-Y; Morizane, C; Hashimoto, Y; Ueshima, K; Ohtomo, T; Tanaka, T; Kudo, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 731PPhase II clinical trial of gemcitabine plus oxaliplatin combination therapy (GEMOX) in patients with advanced pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study). (23rd October 2018) Authors: Takahashi, H; Morizane, C; Nomura, S; Okano, N; Tsuda, M; Mizuno, N; Satake, H; Tsuji, K; Shioji, K; Ishii, H; Yasui, K; Miyakawa, H; Ishiguro, A; Ogura, T; Ueno, M; Ikeda, A; Terashima, T; Ikeda, M; Okusaka, T; Furuse, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial. (30th September 2019) Authors: Morizane, C; Okusaka, T; Mizusawa, J; Katayama, H; Ueno, M; Ikeda, M; Ozaka, M; Okano, N; Sugimori, K; Fukutomi, A; Hara, H; Mizuno, N; Yanagimoto, H; Wada, K; Tobimatsu, K; Yane, K; Nakamori, S; Yamaguchi, H; Asagi, A; Yukisawa, S Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗